CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 70  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0560
LYS 10.0429
GLU 20.0225
LEU 30.0144
ARG 40.0268
CYS 50.0159
GLN 60.0348
CYS 70.0152
ILE 80.0298
LYS 90.0314
THR 100.0111
TYR 110.0262
SER 120.0430
LYS 130.0560
PRO 140.0295
PHE 150.0089
HIS 160.0131
PRO 170.0047
LYS 180.0106
PHE 190.0137
ILE 200.0098
LYS 210.0095
GLU 220.0154
LEU 230.0172
ARG 240.0139
VAL 250.0098
ILE 260.0121
GLU 270.0054
SER 280.0130
GLY 290.0169
PRO 300.0145
HIS 310.0180
CYS 320.0182
ALA 330.0188
ASN 340.0237
THR 350.0203
GLU 360.0099
ILE 370.0068
ILE 380.0149
VAL 390.0143
LYS 400.0163
LEU 410.0161
SER 420.0126
ASP 430.0120
GLY 440.0169
ARG 450.0245
GLU 460.0277
LEU 470.0184
CYS 480.0100
LEU 490.0061
ASP 500.0382
PRO 510.0513
LYS 520.0440
GLU 530.0273
ASN 540.0100
TRP 550.0237
VAL 560.0141
GLN 570.0205
ARG 580.0278
VAL 590.0099
VAL 600.0139
GLU 610.0133
LYS 620.0086
PHE 630.0073
LEU 640.0119
LYS 650.0109
ARG 660.0083
ALA 670.0255
GLU 680.0319
ASN 690.0296

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.